Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Expert Review of Molecular Diagnostics|November 7, 2025
Companion diagnostics and HER2-targeted antibody-drug conjugatesJan Trøst Jørgensen, Kristian Egebjerg
Clinical and Experimental Rheumatology|May 3, 2020
Mortality and cardiovascular morbidity among patients diagnosed with Takayasu's arteritis: a Danish nationwide cohort studyKristian Egebjerg, Bo Baslund, Niels Obel, et al.
Critical Reviews in Oncology/Hematology|April 18, 2021
Prevalence of HER2 overexpression and amplification in squamous cell carcinoma of the esophagus: A systematic review and meta-analysisKristian Egebjerg, Rajendra Singh Garbyal, Jane Preuss Hasselby, et al.
Expert Review of Anticancer Therapy|January 12, 2026
Zolbetuximab as a gastric lineage-directed immunotherapy: mechanistic rationale and translational evidence in CLDN18.2-positive gastroesophageal adenocarcinomaKristian Egebjerg, Florian Lordick, Lisa L Liu, et al.
Frontiers in Oncology|July 12, 2021
HER2 Positivity in Histological Subtypes of Salivary Gland Carcinoma: A Systematic Review and Meta-AnalysisKristian Egebjerg, Cecilie Dupont Harwood, Nina Claire Woller, et al.
Acta Oncologica (Stockholm, Sweden)|May 15, 2024
Implementation of perioperative FLOT compared to ECX/EOX chemotherapy regimens in resectable esophagogastric adenocarcinomas: an analysis of real-world dataKristian Egebjerg, Tobias Sørup Andersen, Lene Bæksgaard, et al.
Journal of Geriatric Oncology|September 25, 2024
Dose reduced preoperative chemotherapy in older patients with resectable gastroesophageal cancer: A real-world data studyJosephine Skjoldbirk, Kristian Egebjerg, Camilla Qvortrup, et al.
Physiological Reports|September 11, 2018
Role of age, Rho-kinase 2 expression, and G protein-mediated signaling in the myogenic response in mouse small mesenteric arteriesKarl Björling, Philomeena D Joseph, Kristian Egebjerg, et al.
Ugeskrift for Laeger|August 11, 2021
[Circulating tumour DNA in the treatment of cancer]Cecilie Riis Iden, Amanda Frydendahl Boll Johansen, Nadia Øgaard, et al.
Frontiers in Immunology|December 29, 2022
Innate immune function during antineoplastic treatment is associated with 12-months survival in non-small cell lung cancerHeidi Ryssel, Kristian Egebjerg, Susanne Dam Nielsen, et al.
Pageof 2